By the end of 2023, Ittinsect will have produced and delivered 1,500 tons of sustainable, nutrient-dense feed for aquaculture. The company will expand its existing product...
The incubator aims to raise at least €700,000 and up to a maximum of €3 million to grow and go public within 3 years. In addition,...
PBEs have doubled the number of clinical trials in the last five years, and their success rates are higher than those of their 'big sisters', according...
Galapagos, a Belgian biotech company, has entered the Italian market this year. The company plans to launch a new product and the first one in Italy,...
The biotech company Valanx has just completed a round of financing. The company will use the new capital to expand its team. One of the goals...
The Strategic Council for Health Industries is making plans to turn France into the number one destination for emerging biotech companies. The council will reduce the...
Genesis Biomed, a company focused on consultancy in the biomedical sector, is bidding hard in the medical industry. Genesis Biomed, directed by Josep Lluís Falcó, intends...